Clinical trial
Effects of an Exclusive Human-milk Diet in Preterm NEOnates on Early VASCular Aging Risk Factors (NEOVASC)
NCT04413994 is registered in ClinicalTrials.gov with Prolacta Bioscience as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of an Exclusive Human-milk Diet in Preterm NEOnates on Early VASCular Aging Risk Factors (NEOVASC)
- Lead sponsor
- Prolacta Bioscience
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- October 9, 2020
- Completion date
- June 1, 2028
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
prematurity, vascular aging